Similar articles

• ICD lead type and RV lead position in CRT-D recipients.

  Benz AP, Vamos M, Erath JW, Bogyi P, Duray GZ, Hohnloser SH. Benz AP, et al. Clin Res Cardiol. 2018 Dec;107(12):1122-1130. doi: 10.1007/s00392-018-1286-3. Epub 2018 May 24. Clin Res Cardiol. 2018. PMID: 29797055
• Sites of left and right ventricular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trial.

  Thébault C, Donal E, Meunier C, Gervais R, Gerritse B, Gold MR, Abraham WT, Linde C, Daubert JC; REVERSE study group. Thébault C, et al. Eur Heart J. 2012 Nov;33(21):2662-71. doi: 10.1093/eurheartj/ehr505. Epub 2012 Jan 26. Eur Heart J. 2012. PMID: 22285578 Clinical Trial.
• Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D.

  Kutyifa V, Bloch Thomsen PE, Huang DT, Rosero S, Tompkins C, Jons C, McNitt S, Polonsky B, Shah A, Merkely B, Solomon SD, Moss AJ, Zareba W, Klein HU. Kutyifa V, et al. Heart Rhythm. 2013 Dec;10(12):1770-7. doi: 10.1016/j.hrthm.2013.08.020. Epub 2013 Aug 22. Heart Rhythm. 2013. PMID: 23973954 Clinical Trial.
• Apical vs. non-apical right ventricular pacing in cardiac resynchronization therapy: a meta-analysis.

  Zografos TA, Siontis KC, Jastrzebski M, Kutyifa V, Klein HU, Zareba W, Katritsis DG. Zografos TA, et al. Europace. 2015 Aug;17(8):1259-66. doi: 10.1093/europace/euv048. Epub 2015 Mar 31. Europace. 2015. PMID: 25829472 Review.
• Cardiac resynchronization therapy pacemaker: critical appraisal of the adaptive CRT-P device.

  Daoud GE, Houmsse M. Daoud GE, et al. Med Devices (Auckl). 2016 Jan 18;9:19-25. doi: 10.2147/MDER.S77940. eCollection 2016. Med Devices (Auckl). 2016. PMID: 26848278 Free PMC article. Review.